Donald Trump nominated Robert F. Kennedy Jr., a vaccine skeptic and harsh critic of federal health agencies, to be his ...

Robert F. Kennedy has espoused a number of unorthodox views on public health, most notably questioning the safety and ...

Novavax’s plans for growth outside of its COVID program have been thrown into chaos after the FDA put two of the biopharma's programs on hold in response to a case of nerve disease from a former ...

The Dow Jones Industrial Average fell 382.15 points, or 0.86%, to 43,910.98, the S&P 500 lost 17.36 points, or 0.29%, to ...

Richmond Fed President Thomas Barkin said earlier in the day that the U.S. central bank is ready to respond if inflation ...

Amgen stock price tanked 7%, Novavax shares plunged 6% ... in the day that the US central bank is ready to respond if ...

The U.S. central bank is ready to respond if inflation pressures rise or the job market weakens ... despite forecasting a ...

Revenue: US$84.5m (down 55% from 3Q 2023). Net loss: US$121.3m (loss narrowed by 7.2% from 3Q 2023). US$0.76 loss per share ...

Vaccine stocks slid late Thursday as reports stated noted anti-vaccine politician Robert Kennedy Jr. will serve as the next ...

Besides Sanofi deal for nuvaxovid, Novavax has few opportunities to generate additional revenue, which likely means its stock ...

Novavax has been gearing up to launch a phase 3 trial of what may result in an important product: A combined flu and coronavirus vaccine. But the company now faces a roadblock, saying regulators ...